GW School of Medicine and Health Sciences and the GW MFA Serve as one of 24 participating trial sites for the NIAID’s COVAIL Trial

Latest News

NIAID observes HIV Vaccine Awareness Day
The GW VRU Director, Dr. David Diemert, weighs in on two candidate vaccine viruses for H5N1 bird flu that could be used to make vaccines in an outbreak.
Study Highlights Need for Defined Markers of Mpox Immunity to Inform Public Health Use